Randong Yang

BRD4 inhibitor MZ1 exerts anti-cancer effects by targeting MYCN and MAPK signaling in neuroblastoma

Xianbing Zhang, Xinyi Guo, Ran Zhuo et al. · Biochemical and Biophysical Research Communications · 2022 · 30 citations

Brd4 Inhibitor Mz1, Anti-cancer Effects, Medicine +7

Novel pharmacological inhibition of JMJD3 improves necrotizing enterocolitis by attenuating the inflammatory response and ameliorating intestinal injury

Shurong Ma, Lingqi Xu, Lulu Chen et al. · Biochemical Pharmacology · 2022 · 20 citations · Full text

Microbial Pathogens, Gastrointestinal Pharmacology, Innate Immune System +30

SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7

Zi-Mu Zhang, Haibo Cao, Zhi-Heng Li et al. · Cell Death and Disease · 2022 · 16 citations · Full text

The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma

Si-qi Jia, Ran Zhuo, Zi-Mu Zhang et al. · Journal of Immunology Research · 2022 · 13 citations · Full text

Suppression of endoplasmic reticulum stress-dependent autophagy enhances cynaropicrin-induced apoptosis via attenuation of the P62/Keap1/Nrf2 pathways in neuroblastoma

Randong Yang, Shurong Ma, Ran Zhuo et al. · Frontiers in Pharmacology · 2022 · 12 citations · Full text